Matches in Wikidata for { <http://www.wikidata.org/entity/Q95273757> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q95273757 description "article scientifique publié en 2020" @default.
- Q95273757 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95273757 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95273757 description "scientific article published on 20 May 2020" @default.
- Q95273757 description "wetenschappelijk artikel" @default.
- Q95273757 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95273757 name "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 name "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 type Item @default.
- Q95273757 label "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 label "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 prefLabel "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 prefLabel "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 P1433 Q95273757-1DA9250C-93F8-4D4F-ABFD-20FFDF54F4E5 @default.
- Q95273757 P1476 Q95273757-15F4EDD0-E6BB-48B5-9104-3565BFCD9ADD @default.
- Q95273757 P2093 Q95273757-03848AC7-DC41-40DE-978B-A76F6DA9585A @default.
- Q95273757 P2093 Q95273757-3363405A-E5F8-4C48-A636-6DDB8D74001C @default.
- Q95273757 P2093 Q95273757-7F1316D0-DCC2-4575-A0BD-931E5D52AD52 @default.
- Q95273757 P2093 Q95273757-9BAD286B-3B2C-40BD-A8F3-9638313078B2 @default.
- Q95273757 P31 Q95273757-728B2538-66BE-415F-A6FE-E66EC32DA177 @default.
- Q95273757 P356 Q95273757-50FAB3F9-A1EB-4688-8427-D1109505E65D @default.
- Q95273757 P50 Q95273757-3F3890D3-AECA-48E7-9C8C-4EADC3741E4B @default.
- Q95273757 P577 Q95273757-0DE0BED6-501B-4A23-BE2F-C1C481CF57DC @default.
- Q95273757 P698 Q95273757-905DEB8C-9FFC-42F5-9E7A-A2646B50A7CF @default.
- Q95273757 P921 Q95273757-032EFBDB-8BD7-4D72-9464-C8F126CA4BAA @default.
- Q95273757 P356 S11033-020-05532-1 @default.
- Q95273757 P698 32436041 @default.
- Q95273757 P1433 Q15752755 @default.
- Q95273757 P1476 "Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression" @default.
- Q95273757 P2093 "Amir Reza Afshari" @default.
- Q95273757 P2093 "Baratali Mashkani" @default.
- Q95273757 P2093 "Fariba Mohammadi" @default.
- Q95273757 P2093 "Hossein Javid" @default.
- Q95273757 P31 Q13442814 @default.
- Q95273757 P356 "10.1007/S11033-020-05532-1" @default.
- Q95273757 P50 Q79931349 @default.
- Q95273757 P577 "2020-05-20T00:00:00Z" @default.
- Q95273757 P698 "32436041" @default.
- Q95273757 P921 Q108442577 @default.